H.C. Wainwright Reiterates Buy Rating on Halozyme Therapeutics (HALO)
Go back to H.C. Wainwright Reiterates Buy Rating on Halozyme Therapeutics (HALO)| Halozyme Therapeutics, Inc. (NASDAQ: HALO) | Delayed: 69.82 +3.54 (5.34%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $66.28 | 52 Week High | $18.39 | |||
| Open | $66.00 | 52 Week Low | $6.96 | |||
| Day High | $70.13 | P/E | N/A | |||
| Day Low | $66.00 | EPS | $-0.58 | |||
| Volume | 2,144,789 | |||||
